Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections-A prospective cohort study.

Maurin Lampart Núria M ZellwegerStefano BassettiSarah Tschudin-SutterKatharina M RentschMartin SiegemundRoland BingisserStefan OsswaldGabriela M KusterRaphael Twerenbold

Published in: PloS one (2022)

In patients with COVID-19 and other respiratory infections, inflammatory biomarkers harbour strong prognostic information, particularly IL-6 and CRP. Their routine use may support early management decisions.

Keyphrases

coronavirus disease
oxidative stress
sars cov
respiratory tract
clinical practice
health information
respiratory syndrome coronavirus
clinical evaluation